Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series C
Biotech
Enveda envisions clinical wins with $130M series C raise
The Boulder-based biotech sent its lead candidate ENV-294 into a phase 1 trial for atopic dermatitis at the end of October.
Darren Incorvaia
Nov 21, 2024 10:55am
Radiopharma Alpha-9 raises $175M series C to fund clinical push
Oct 23, 2024 9:15am
Scorpion snaps up $150M series C to broaden clinical plans
Jul 16, 2024 9:40am
Asceneuron raises $100M series C for ph. 2 Alzheimer's trial
Jul 16, 2024 3:00am
Zenas bags $200M series C to reach a handful of key mAB readouts
May 7, 2024 7:00am
Infectious disease DNA tester Karius nets $100M
May 3, 2024 12:18pm
